Evaluation of Anticancer Activity of Zhubech, a New 5-FU Analog Liposomal Formulation, against Pancreatic Cancer
International Journal of Molecular Sciences · 2023
DOI: 10.3390/ijms24054288 ↗Kurz gefasst
Fachartikel in der Zeitschrift International Journal of Molecular Sciences, 2023. Verfasst von Nkafu Bechem Ndemazie und 9 weiteren Autor:innen. Beteiligte Einrichtung: College of Pharmacy and Pharmaceutical Sciences, Florida A&M University, Tallahassee, FL 32307, USA. Hauptthemen laut MEDLINE: Pancreatic Neoplasms, Nanoparticles. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 58 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NIH HHS, NIMHD NIH HHS, NCI NIH HHS.
Abstract (Originalsprache)
Pancreatic cancer is projected to be the second leading cause of cancer-related death by 2030 in the US. The benefits of the most common systemic therapy for various pancreatic cancers have been masked by high drug toxicities, adverse reactions, and resistance. The use of nanocarriers such as liposomes to overcome these unwanted effects has become very popular. This study aims to formulate 1,3-bistertrahydrofuran-2yl-5FU (MFU)-loaded liposomal nanoparticles (Zhubech) and to evaluate itsstability, release kinetics, in vitro and in vivo anticancer activities, and biodistribution in different tissues. Particle size and zeta potential were determined using a particle size analyzer, while cellular uptake of rhodamine-entrapped liposomal nanoparticles (Rho-LnPs) was determined by confocal microscopy. Gadolinium hexanoate (Gd-Hex) was synthesized and entrapped into the liposomal nanoparticle (LnP) (Gd-Hex-LnP), as a model contrast agent, to evaluate gadolinium biodistribution and accumulation by LnPs in vivo using inductively coupled plasma mass spectrometry (ICP-MS). The mean hydrodynamic diameters of blank LnPs and Zhubech were 90.0 ± 0.65 nm and 124.9 ± 3.2 nm, respectively. The hydrodynamic diameter of Zhubech was found to be highly stable at 4 °C and 25 °C for 30 days in solution. In vitro drug release of MFU from Zhubech formulation exhibited the Higuchi model (R2 value = 0.95). Both Miapaca-2 and Panc-1 treated with Zhubech showed reduced viability, two- or four-fold lower than that of MFU-treated cells in 3D spheroid (IC50Zhubech = 3.4 ± 1.0 μM vs. IC50MFU = 6.8 ± 1.1 μM) and organoid (IC50Zhubech = 9.8 ± 1.4 μM vs. IC50MFU = 42.3 ± 1.0 μM) culture models. Confocal imaging confirmed a high uptake of rhodamine-entrapped LnP by Panc-1 cells in a time-dependent manner. Tumor-efficacy studies in a PDX bearing mouse model revealed a more than 9-fold decrease in mean tumor volumes in Zhubech-treated (108 ± 13.5 mm3) compared to 5-FU-treated (1107 ± 116.2 mm3) animals, respectively. This study demonstrates that Zhubech may be a potential candidate for delivering drugs for pancreatic cancer treatment.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- College of Pharmacy and Pharmaceutical Sciences, Florida A&M University, Tallahassee, FL 32307, USA.
- Faculty of Health Sciences, University of Buea, Buea P.O. Box 63, Cameroon.
- Department of Medicine, University of Florida, Gainesville, FL 32608, USA.
- Department of Surgery, Keck School of Medicine University of South California, Los Angeles, CA 90033, USA.
ORCID-Profile: Nkafu Bechem Ndemazie, Esther Kesewaah Frimpong, Bo Han
Förderung
- NIH HHS
- NIMHD NIH HHS
- NCI NIH HHS
- National Cancer Institute (NCI) of the National Institutes of Health (NIH)
- National Institute of Health (NIH) National Institute on Minority Health and Health Disparities (NIMHD)
- Title III of Florida A&M University
Zitieren
APA
Ndemazie, N. B., Bulusu, R., Zhu, X. Y., Frimpong, E. K., Inkoom, A., Okoro, J., Ebesoh, D., Rogers, S., Han, B., & Agyare, E. (2023). Evaluation of Anticancer Activity of Zhubech, a New 5-FU Analog Liposomal Formulation, against Pancreatic Cancer. International Journal of Molecular Sciences. https://doi.org/10.3390/ijms24054288
Vancouver
Ndemazie NB, Bulusu R, Zhu XY, Frimpong EK, Inkoom A, Okoro J, et al. Evaluation of Anticancer Activity of Zhubech, a New 5-FU Analog Liposomal Formulation, against Pancreatic Cancer. International Journal of Molecular Sciences. 2023. doi:10.3390/ijms24054288
BibTeX
@article{Ndemazie2023,
author = {Ndemazie, Nkafu Bechem and Bulusu, Raviteja and Zhu, Xue You and Frimpong, Esther Kesewaah and Inkoom, Andriana and Okoro, Joy and Ebesoh, Dexter and Rogers, Sherise and Han, Bo and Agyare, Edward},
title = {Evaluation of Anticancer Activity of Zhubech, a New 5-FU Analog Liposomal Formulation, against Pancreatic Cancer},
journal = {International Journal of Molecular Sciences},
year = {2023},
doi = {10.3390/ijms24054288}
}
EUVIMED